Fifth Eye
Fifth Eye developed medical device software providing clinicians with a view of a patient's evolving hemodynamic trajectory, serving hospital systems with clinical surveillance and decision support. Acquired by AirStrip Technologies in 2023; no longer operates independently.
- Company typePrivate
- Founded2017
- HeadquartersAnn Arbor, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
Fifth Eye firmographics
Firmographics- Name
- Fifth Eye
- Legal name
- Fifth Eye
- Website
- https://fiftheye.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Acquired
- Headcount range
- 11–50 employees
- Short description
- Fifth Eye developed medical device software providing clinicians with a view of a patient's evolving hemodynamic trajectory, serving hospital systems with clinical surveillance and decision support. Acquired by AirStrip Technologies in 2023; no longer operates independently.
- Ownership category
- akta.pro rank
Where Fifth Eye is headquartered
LocationHeadquarters
- HQ city
- Ann Arbor
- HQ country
- United States
- HQ region
- North America
Markets served
Fifth Eye business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations
Fifth Eye product offering
Product offeringCore offering
Fifth Eye developed medical device software that provides clinicians with a view of a patient's evolving hemodynamic trajectory. The product functioned as a clinical surveillance and decision support tool for hospitals, designed to surface early indicators of patient deterioration from continuous hemodynamic data streams. Following its 2023 acquisition by AirStrip Technologies, the offering now sits within AirStrip's broader clinical surveillance portfolio.
Differentiator
Problem solved
Functional benefit
Products and services
- Hemodynamic Trajectory Clinical Surveillance Software
Companies that use Fifth Eye
Customer profileSegments1 record
Ideal customer profiles1 record
Fifth Eye technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Fifth Eye partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- AirStrip TechnologiescoreFifth Eye was acquired by AirStrip Technologies in 2023 alongside DecisionHealth. AirStrip Technologies develops clinical surveillance and decision support tools for hospitals. Following the acquisition, Fifth Eye operates as part of AirStrip's portfolio of healthcare technology solutions.
Scale indicators1 record
Fifth Eye competitors and assessment
Company assessmentBroad incumbents
- AirStrip Technologies: AirStrip acquired Fifth Eye in 2023 and operates a broader clinical surveillance and decision support platform for hospitals. It is the most directly comparable company as both the acquirer and a provider of overlapping hospital clinical surveillance capabilities.
- Masimo: Masimo is a major patient monitoring and hemodynamic monitoring vendor with hospital-focused clinical decision support tools (e.g., SedLine, O3 regional oximetry). It represents the large incumbent that Fifth Eye's hemodynamic trajectory software would have competed against.
- GE HealthCare: GE HealthCare offers a broad portfolio of hospital patient monitoring, clinical decision support, and analytics solutions. Its enterprise scale and installed base in ICUs and ORs make it a key adjacent incumbent in the hospital hemodynamic monitoring space.
- Philips: Philips provides patient monitoring and clinical informatics solutions to hospitals globally, including hemodynamic monitoring. It is a broad incumbent competitor with overlapping clinical decision support capabilities.
- Edwards Lifesciences: Edwards Lifesciences is the leader in hemodynamic monitoring (e.g., FloTrac, HemoSphere) with deep hospital ICU and OR penetration. Any software-only hemodynamic decision support company like Fifth Eye would have competed with Edwards' integrated offering.
- Medtronic: Medtronic's Patient Monitoring business (post-Covidien acquisition) provides continuous hemodynamic and vital signs monitoring solutions to hospitals, making it a relevant incumbent in the same clinical surveillance category.
- Baxter (Hillrom Connected Care): Baxter's acquisition of Hillrom brought connected care and patient monitoring solutions (including the Voalte mobile platform) into hospitals. It is a broad incumbent with overlapping clinical surveillance capabilities.
- Stryker: Stryker's Medical division includes patient handling, ICU equipment, and increasingly connected hospital solutions. While not a direct hemodynamic software peer, it is a broad incumbent that competes for hospital clinical workflow budgets.
- Oracle Health (Cerner): Oracle Health (Cerner) provides enterprise EHR and clinical decision support infrastructure to hospitals. Its installed base makes it a strategic channel and competitor for any clinical surveillance software targeting hospital integration.
Emerging players
- iRhythm Technologies: iRhythm is a digital health company that applies algorithmic analysis to ambulatory cardiac monitoring data. While focused on cardiac arrhythmias rather than inpatient hemodynamics, it represents an emerging software-driven patient monitoring peer with a similar clinical analytics positioning.
Market position
Customer concentration
Fifth Eye social profiles
Digital presenceFifth Eye financial estimates
Financial estimateRevenue estimate
Valuation estimate
Fifth Eye leadership team
Management profileNumber of profiles
Profiles3 records
Fifth Eye funding detail
Funding detailFunding overview
Funding rounds3 records
Investors6 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Fifth Eye M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Fifth Eye
What does Fifth Eye do?
Fifth Eye developed medical device software that provides clinicians with a view of a patient's evolving hemodynamic trajectory. The product functioned as a clinical surveillance and decision support tool for hospitals, designed to surface early indicators of patient deterioration from continuous hemodynamic data streams. Following its 2023 acquisition by AirStrip Technologies, the offering now sits within AirStrip's broader clinical surveillance portfolio.
Is Fifth Eye a public or private company?
Fifth Eye is a private company. It is classified as corporate owned and is currently acquired.
When was Fifth Eye founded?
Fifth Eye was founded in 2017. It employs 11 to 50 people.
Where is Fifth Eye based?
Fifth Eye is headquartered in Ann Arbor, United States, in the North America region.
Who are Fifth Eye's main competitors?
Broad incumbents on record are AirStrip Technologies, Masimo, GE HealthCare, Philips, Edwards Lifesciences, Medtronic, Baxter (Hillrom Connected Care), Stryker and Oracle Health (Cerner). iRhythm Technologies is listed as an emerging player.
Does Fifth Eye have an API?
No public API is recorded for Fifth Eye.